← All courses at Queen Mary University of London

BSc Pharmacology and Innovative Therapeutics

Queen Mary University of London

Institution
Queen Mary University of London
Level
undergraduate
Subject
Pharmacology and Innovative Therapeutics
Duration
3 years
UCAS code
B211
Typical offer
A-level ABB, IB 32
Median salary
£50,500 after 5 years

Entry requirements

Pharmacology and Innovative Therapeutics - BSc (Hons): A-Level: Grades ABB at A-Level. This must include A-Level Biology or Chemistry. A second science subject at A-Level, of Biology, Chemistry, Maths or Physics is also required. IB: International Baccalaureate Diploma with a minimum of 32 points overall, including 6,5,5 from three Higher Level subjects. This must include Biology and Chemistry at Higher Level. BTEC: BTEC qualifications are not considered for entry to this programme. Access HE: Access qualifications are not considered for entry to this programme. GCSE: Minimum five GCSE passes including English and Maths at grade C or 4. Contextualised admissions: Our standard contextual offer: Grades BBC including BB in Biology or Chemistry and one further science subject from Chemistry, Maths, Further Maths or Physics at A-Level. Our enhanced contextual offer: Grades BCC including B in Biology or Chemistry and one further science subject from Chemistry, Maths, Further Maths or Physics at A-Level. More information on our contextual offer criteria can be found on our contextualised admissions page . Please note that General Studies and Critical Thinking are excluded from any A-Level offer and cannot be considered.

See the highest paying Nursing, Pharmacy & Allied Health degrees in the UK →

What students say

Based on about 33 final-year students who answered, across similar courses at this university

  • Teaching on my course: 90%
  • Learning opportunities: 88%
  • Assessment and feedback: 85%
  • Academic support: 95%
  • Organisation and management: 85%
  • Learning resources: 89%
  • Student voice: 91%

Do students stay on the course?

Based on about 45 students who started, across similar courses at this university

  • Continued on course: 90%
  • Left higher education: 5%
  • Moved to a lower qualification: 5%

What graduates do next

Based on about 16 graduates who answered, across similar courses at this university (a small group: a rough guide only)

  • Working: 55%
  • Working and studying: 10%
  • Further study: 25%
  • Unemployed: 5%

Most common jobs

  • Natural and social science professionals: 25%
  • Sales occupations: 15%
  • Other Educational Professionals: 15%
  • Business and public service associate professionals: 15%
  • Elementary occupations: 10%
  • Find their work meaningful: 55%
  • Feel on track for their future plans: 45%
  • Use what they learnt on the course: 35%

Where graduates work (5 years on)

Based on about 120 graduates, across similar courses at this university

  • North East: 1%
  • North West: 2%
  • Yorkshire and the Humber: 5%
  • East Midlands: 2%
  • West Midlands: 3%
  • East of England: 13%
  • London: 53%
  • South East: 16%
  • South West: 3%
  • Wales: 1%
  • Scotland: 3%

Who gets in

Based on about 80 students who started, across similar courses at this university

  • A levels: 90%
  • Foundation course: 6%
  • Other qualifications: 4%

Accreditation & quality ratings

TEF 2023 (whole university): Silver overall, Bronze for student experience, Silver for student outcomes.

Modules

  • Communication in Science and Technology
  • Science and Engineering Success
  • Foundations of Chemical Science
  • Foundations of Physical Science
  • Foundations of Engineering
  • Foundations of Biological Science
  • Mathematics A
  • Biomedical Physiology I - Exchange, Movement and Integration
  • Biomolecules of Life
  • Cells
  • Human Anatomy
  • Introduction to Pharmacology
  • Genetics
  • Research Skills for Pharmacologists
  • Tissue Biology
  • Basic Immunology
  • Biomedical Physiology II - Cardiovascular and Respiratory
  • Clinical Pharmacology and the Assessment of Drug Safety
  • Drug Target Identification
  • Biomolecules of Life II
  • The Business of Pharmacology
  • Cellular and Molecular Neuroscience
  • Human Genetic Disorders
  • Membrane and Cellular Biochemistry
  • Research Design and Analysis
  • Classic Papers and Current Topics in Pharmacology
  • Clinical Trials and Regulatory Affairs
  • Drug Design
  • Translational Pharmacology and Innovative Therapeutics
  • Project: Engaging the Public with Science
  • Structured Research Project in the Life Sciences
  • Research Project in Pharmacology
  • Advanced Human Genetic Disorders
  • Advanced Immunology
  • Biomarkers in Neuroscience
  • Cancer Biology
  • Molecular Basis of Personalised Medicine
  • Stem Cells and Regenerative Medicine

Questions about this course

How much do graduates of BSc Pharmacology and Innovative Therapeutics at Queen Mary University of London earn?

The median salary is £27,000 after 15 months, £40,000 after 3 years, £50,500 after 5 years. After five years the middle half of graduates earn between £45,500 and £57,500. The £50,500 median after five years is £15,000 more than the UK median for Pharmacology.

What do graduates of BSc Pharmacology and Innovative Therapeutics at Queen Mary University of London do next?

90% were in work or further study 15 months after finishing (Graduate Outcomes 2022-23).

Are students happy with the teaching on BSc Pharmacology and Innovative Therapeutics at Queen Mary University of London?

90% of final-year students were positive about the teaching in the National Student Survey 2024-25.

What grades do I need for BSc Pharmacology and Innovative Therapeutics at Queen Mary University of London?

The typical offer is ABB at A level, or 32 points in the IB. The average entrant had 140 UCAS points.

Does BSc Pharmacology and Innovative Therapeutics at Queen Mary University of London include a placement year or year abroad?

The course has a compulsory year abroad.

How many students continue on BSc Pharmacology and Innovative Therapeutics at Queen Mary University of London?

90% of students continued into their second year, and 5% left higher education.